Toronto, Ontario–(Newsfile Corp. – September 30, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that its science division, Scarlette Lillie Science and Innovation (“Scarlette Lillie“), has secured a relationship with Jinfiniti Precision Medicine (“Jinfiniti“) in order to explore the potential roles that psilocybin and truffles can play for age-related and psychiatric disorders. Jinfiniti has created a world class “AgingSOS” test panel that can detect key factors from blood that drive aging and other genetic instabilities. The speed and affordability of this test can allow for both company’s Scientists to clearly evaluate the potential for psilocybin treatments that go beyond what is currently being explored. The CEO of Jinfiniti is Dr. Jin-Xiong She, a professor at Augusta University in Georgia, USA, whose expertise is in the creation of biomarker panels. Jinfiniti’s state of the art panel is making it possible to extend the applicability of psilocybin.
“We are pleased to work with Scarlette Lillie, and we are excited to add this special dimension to their clinical study explorations as they emerge,” says Dr. She, CEO of Jinfiniti.
“The idea that psilocybin and truffles have deep physiological and medicinal effects that go beyond psychiatric applications is not new, but as a scientist, Scarlette Lillie is allowing me to truly explore whole new markets, with a rigorous biomarker panel. Additionally, this work has the potential to help us understand if there are unknown mechanisms at play for neurological and psychiatric disorders,” says Dr. Joseph Geraci, CEO of NetraMark Corp. and a scientific advisor to Red Light Holland. Dr. Geraci is helping to establish several clinical programs. He brings a deep knowledge of systems biology, medical science, and artificial intelligence to the team.
This relationship with Jinfiniti will allow Scarlette Lillie to add a novel component to expected clinical studies for psilocybin and truffles. The knowledge that comes from this has the potential to not only influence the outcome of clinical studies but can also potentially lead to novel treatments for several disorders.
“When you see brilliant Scientists like Dr. Joseph Geraci and Dr. Jin-Xiong She, a professor at Augusta University, show this much excitement, it gets me really excited!” Added Todd Shapiro, CEO and Director of Red Light Holland. “I’ve always made it very clear that as a company we take Science and Innovation very seriously. This is just another example of Scarlette Lillie moving forward intelligently with world class experts to hopefully help be a part of positive change.”
About Jinfiniti Precision Medicine
Jinfiniti is a precision medicine company that aims to increase the human healthspan. Using measures of key blood biomarkers, Jinfiniti is able to provide a detailed overview of individual aging health. Composed of researchers who met at the Medical College of Georgia, the Jinfiniti team is dedicated to the prevention of chronic disease and the promotion of longevity. Their novel approach to anti-aging practices involves conducting lab tests to measure aging biomarkers within the blood. This information then helps to guide individual lifestyle adjustments, leading to improved health and quality of life.
Jin-Xiong She, Ph.D., Professor at Augusta University
Founder & CEO
Jinfiniti Precision Medicine, Inc.
1120 15th Street, Augusta, GA 30912
About Red Light Holland Corp.
RLH is an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws. The Company’s brand of magic truffles are expected to be sold in the Netherlands through existing Smart Shops as well as its e-commerce platform, and are expected to be initially made available in the form of its previously announced Microdosing Packs.
For additional information on the Company:
Chief Executive Officer and Director
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend” or the negative of these terms and similar expressions. Forward-looking statements necessarily involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions, or expectations upon which they are placed will occur. Readers are further cautioned that the assumptions used in the preparation of such forward-looking statements (including, but not limited to, the assumption that (i) the Company will be able to execute on its business plan, and will receive one or multiple licenses, permits, and authorizations from time to time necessary to execute on its business plan, (ii) the Company’s financial condition and development plans do not change as a result of unforeseen events, (iii) there will continue to be a demand, and market opportunity, for the Company’s product offerings, (iv) the Company will be able to establish, preserve and develop its brand, and attract and retain required personnel, (v) the establishment and success of the Company’s planned clinical trials, uncertainties associated with the Company’s planned clinical trials and planned studies, uncertainties associated with any results of the Company’s planned clinical trials and studies, uncertainties associated with the clinical development process, regulatory submission and approval process, the use of Jinfiniti’s technology in any proposed trials and studies and its impact on the Company’s planned clinical trials, (vi) current and future economic conditions will neither affect the business and operations of the Company nor the Company’s ability to capitalize on anticipated business opportunities, and (vii) the magic truffles currently being grown by the Company will be ready for harvest and distribution within the timelines anticipated by the Company, and in particular, will pass the testing criteria established by the Company), although considered reasonable by management of the Company at the time of preparation, may prove to be imprecise and result in actual results differing materially from those anticipated, and as such, undue reliance should not be placed on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws. Forward-looking statements, forward-looking financial information and other metrics presented herein are not intended as guidance or projections for the periods referenced herein or any future periods, and in particular, past performance is not an indicator of future results and the results of the Company in this news release may not be indicative of, and are not an estimate, forecast or projection of the Company’s future results. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/64888
Greene Concepts Fortifies Financial Positioning Through Major Debt Reduction Combined with Share Buyback in Alignment with the Company’s Growth Strategy
Marion, North Carolina–(Newsfile Corp. – October 28, 2020) – Greene Concepts Inc. (OTC Pink: INKW) is excited to report the company has completed a debt forgiveness agreement in the amount of $340,898 previously owed to one of our largest note holders. This reduces our notes payable by 56%. The debt holder, Greene Concepts’ management and accountants have agreed to write-off and eliminate $340,898 of the third-party convertible notes from the company’s finances as debts that are no longer due.
Additionally, the Company is in the process of finalizing a substantial share buyback of its common stock. This common stock buyback will reduce the common share count by over 280 million shares. The company has taken powerful actions financially in a short time span by increasing its Assets, Cash, Inventory, and Sales.
|Greene Concepts 3rd and 4th Quarter Finance Comparisons|
|3rd Quarter Report (Period Ending 4/30/2020)||4th Quarter Annual Report (Period Ending 7/31/2020)|
Lenny Greene, CEO of Greene Concepts notes, “Today’s announcement marks an important step forward in significantly strengthening Greene Concepts in terms of debt reduction which wipes out 56% of our debt (over $340,000 worth of payable debt) off our books. We would like to give a profound thanks to this Debt holder for their strong work and altruism in this action. This bold and forward-looking gesture better positions us for increased revenue generation, faster inventory turnaround times, increased gross and profit margins, a rise in working capital, employee additions and positive cash flows. It also allows us to increase our assets, our cash reserves, and our total sales. We will continue to focus on the things we can control with aggressive cost management and working capital reductions. This focus will allow us to reduce debt, achieve positive liquidity and balance sheet improvement.”
Mr. Greene continues, “We are pleased to continue making strides in our ongoing efforts to strengthen our business, increase our flexibility and improve returns on capital. It is our intention to do whatever we can to continually reduce our debt and monitor our Key Performance Indicators for our financial condition to include our cash, accounts receivable and accounts payable. While we amplify our sales and reduce our debt, we also maintain an inventory of $51,425 of cases of our bottled ‘Be Water’ Brand ready to ship to Amazon and throughout the country. Our new ‘Be Water’ Label production run begins next week.”
BeWater New Label
To view an enhanced version of this graphic, please visit:
“Finally, we are in the process of finalizing a share buyback of our stock. This common share buyback will reduce our common share count by over 280 million shares. We are confident that each of these financial actions offer improved security during these uncertain times and better positions us to pull the trigger on future partnership or acquisition opportunities while preparing us for unprecedented growth.”
Greene Concepts Creek Running Water
To view an enhanced version of this graphic, please visit:
About Greene Concepts, Inc., Mammoth Ventures, Inc. and Water Club, Inc.
Greene Concepts, Inc. (http://www.greeneconcepts.com) is a publicly traded company. Through its recently acquired wholly owned subsidiary, Mammoth Ventures Inc., the Company has entered the specialty beverage and bottling business and is an emerging leader in the global scientifically formulated beverage industry. Through its subsidiary Water Club, Inc. we intend to pursue subscription-based delivery of water and scientifically formulated beverages directly to the consumers home and market the convenience of this service thru social media affiliate marketing partners.
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company’s current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company’s business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Greene Concepts, Inc.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/67028
TransGlobal Assets Inc. (TMSH) Expands in Pittsburgh Area with Property Acquisition
Company seeks a foothold on manufacturing of Monster Elixir branded CBD products and beverages
Pittsburgh, Pennsylvania–(Newsfile Corp. – October 28, 2020) – TransGlobal Assets, Inc. (OTC Pink: TMSH) is proud to announce the purchase of a 3,500 square foot building in Pittsburgh that will serve as the headquarters of Monster Elixir Inc., a wholly-owned subsidiary. It will house manufacturing for Monster Elixir’s line of CBD beverages and topical healing products.
To view an enhanced version of this graphic, please visit:
The purchase expands on the company’s growth plan, which currently features a 2,400 square foot rental space in the city that will be a storage unit for production. The plan also entails the purchase of the first of many additional store front retail spaces in the Pittsburgh area.
The company is securing space for its line of heavily demanded drinks called Green Essence Beverages. The CBD-infused drinks will be sold in the following flavors:
Pineapple Agave (Dark)
Strawberry Pineapple Lemonade
Monster Elixir will also launch a line of CBD wellness products that include, but are not limited to, the following:
Joint & Muscle Cream
Joint & Muscle Balm
In addition, the company is also launching a line of hemp-infused hair care products that will include shampoos & conditioners, healthy hair butters & tinctures, as well as beard care products. These fine CBD products will be sold at local dispensaries and other retail outlets.
For further inquiries please contact:
Curtis Philpot CEO
TransGlobal Assets Inc.
Office: (833) 217-8764
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/67026
Hemp, Inc. Set to Distribute Full King of Hemp® Product Line Across Country
Las Vegas, NV, Oct. 28, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Hemp, Inc. (OTC PINK: HEMP), a global leader in the industrial hemp industry with bi-coastal processing centers, announced today it will be aggressively shipping its King of Hemp® product line to stores across the country over the next 30-60 days. To date, the King of Hemp® product line consists of Bubba Kush hemp; Pre-rolls, Fortified Pre-rolls, Caviar/Moon Rocks; and Diamonds.
According to Bruce Perlowin, CEO of Hemp, Inc., the Company is revving up to launch one of its most aggressive marketing campaigns to date. “Our number one goal has been to produce top-of-the-line CBD and CBG smokable products and CBD consumption options that fit consumer lifestyles and deliver unparalleled results. We’ve done just that with the King of Hemp® line.”
Hemp, Inc.’s Diamonds and Crumbles (smaller Diamond pieces) are dabbable CBD products, derived from a golden-hued high CBD, THC-free distillate taken directly from the hemp plant that includes blends of valuable terpenes. Diamonds and Crumbles promise to deliver the strongest, most potent effects of any other product from the line containing between 92% and 98.7% pure CBD.
Consumption methods include, but are not limited to, utilizing a dab rig or a wax vaporizer for the fastest, strongest results. (While Hemp, Inc. does not cultivate, manufacture or produce any type of THC product, consumers of the Company’s CBD product Diamonds report that mixing Diamonds with a THC concentrate helps to mellow THC’s effects).
“Diamonds or Crumbles are the perfect way for our customers to get a pure, clean CBD dabbing experience with instant results that last,” said Perlowin.
Hemp, Inc.’s Caviar, similar to Moon Rocks, is a highly potent and rich tasting smokable product with less than 0.3% THC. It is made from Hemp, Inc.’s high-quality Southern Oregon-grown Bubba Kush hemp flower, which is covered with a THC-Free distillate (with and without added terpenes), and then rolled in CBG-rich kief. The product contains over 45% CBD and over 10% CBG.
Many people prefer to smoke their hemp products due to the speed and effectiveness of the delivery system. By entering the body through the respiratory system, there is a dramatic increase in bioavailability as compared to oral consumption. It is the fastest way to receive CBD and CBG’s potential calming and pain-relieving benefits.
Consumption methods include but are not limited to vaporizing Caviar in an all-ceramic or stainless steel vaporizer to capture the full terpene profile and cannabinoid effects; or using a glass water pipe. While Caviar is not a cannabis product, smoking it the way hash is smoked is recommended to achieve the best results.
“Caviar exemplifies the variety of ways consumers can enjoy CBD and CBG and reflects our brand vision of providing a superior, royal experience,” said Perlowin.
The King of Hemp® pre-roll line offers high-end products that are an effective and flavorful, smokable alternative to cigarettes and other hemp consumption methods. The King of Hemp® pre-rolls can be purchased individually or in packs of 6. Each pre-roll is 1 gram and does not exceed 0.3% THC.
King of Hemp® pre-rolls use A and B hemp colas which are derived from Pre-98 OG Bubba Kush hemp, one of the top selling cultivars on the market. The strain, rich soil and climate lend themselves to these colas being among the highest quality buds, positioning them to be some of the best tasting for consumption.
The Company’s website for its King of Hemp® line (www.kingofhempusa.com) also has CBD oil tinctures available for purchase. The tinctures are available in two flavors, Natural and Peppermint, and contain full-spectrum hemp oil extracted from the flowers and leaves of hemp plants sustainably sourced from Colorado. They are also compliant with the regulations created by the Colorado Department of Agriculture in regards to industrial hemp. The tinctures contain 0.3% or less THC and are compliant with the 2018 Farm Bill.
To learn more, go to the King of Hemp® website, here.
According to Nielsen, market researchers project 2020 sales in the current smokable-hemp market to reach $70 million to $80 million. This category includes loose CBD flower, hemp-CBD pre-rolls, cigars and other inhalables.
To see one-minute videos of Hemp, Inc.’s current activities, visit Bruce Perlowin’s personal Facebook fan page, where he shares posts of Hemp, Inc.’s activities around the country. Additionally, follow Hemp, Inc. on Instagram here and on Twitter here.
To view the webinar featuring Hemp, Inc.’s CEO, Bruce Perlowin, click here.
WHAT IS HEMP, INC.?
What is Hemp, Inc.? With a deep-rooted social and environmental mission at its core, Hemp, Inc. seeks to build a business constituency for the American small hemp farmer, the American veteran, and other groups experiencing the ever-increasing disparity between tapering income and soaring expenses. The Company is on a mission to be a powerful engine for social change and economic revival, worldwide, by providing hemp products that are eco-friendly, sustainable and healthy. Hemp, Inc. executives believe there can be tangible benefits reaped from adhering to a corporate social responsibility plan.
FORWARD-LOOKING DISCLAIMER AND DISCLOSURES
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. The Securities and Exchange Commission (SEC) requires issuers to provide “adequate current information” and Hemp, Inc. does… using the SEC’s Alternative Reporting Standard to publicly report its quarterly and yearly financials. All current information can be found on www.hempinc.com/hemp-financial-disclosures/. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.
Cannabis4 weeks ago
MustGrow Commences Banana ‘Panama Disease’ Testing in Colombia
Cannabis3 weeks ago
Bud & Tender® raise testing and quality standards for best CBD oil in the UK
Cannabis3 weeks ago
The World’s Greatest Weight Loss Secret May be Psilocybin
Cannabis2 weeks ago
Aither Ingredients Announces Joint Venture With Thar Process Intended to Disrupt the Canadian Cannabis-based Ingredient Market
Cannabis4 weeks ago
WeedMD Reports Second Quarter 2020 Financial Results and Closes $30 Million Credit Facility with LiUNA Pension Fund
Cannabis4 weeks ago
PAOG Engages Saul Kaye, Founder of iCAN: Israel-Cannabis and CannaTech to Prepare RespRx for IND
Cannabis4 weeks ago
Christina Lake Announces Commencement of Trading on the CSE
Cannabis2 weeks ago
IGNITE Files Q2 2020 Financial Statements and MD&A